Laurie Sehn, MD, MPH, chair of the lymphoma tumor group, BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada, provides an update on B-cell lymphoma research from the 2022 American Society of Hematology Annual Meeting. Dr Sehn discusses finding from the POLARIX Phase 3 trial, the rapid evolution in NHL management, and significant findings in novel target therapies and immunotherapies.